Effects of Nonsteroidal Anti-Inflammatory Drugs in Recurrence of Spondyloarthritis Patients After Remission
NCT03425812 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140
Last updated 2022-04-18
Summary
The multicenter, randomized controlled trial is to investigate and evaluate the effect of NSAIDs therapy on recurrence in patients with axial spondyloarthritis;
Conditions
- Axial Spondyloarthritis
Interventions
- DRUG
-
To withdraw NSAIDs therapy
NSAIDs therapy will be withdrew after washout period.
- DRUG
-
To continue NSAIDs therapy
NSAIDs therapy will be continued.
Sponsors & Collaborators
-
First Affiliated Hospital of Fujian Medical University
collaborator OTHER -
Peking University Shenzhen Hospital
collaborator OTHER -
Zhangzhou Affiliated Hospital of Fujian Medical University
collaborator OTHER -
Quanzhou Orthopedic-traumatological Hospital of Fujian Traditional Chinese Medicine University
collaborator UNKNOWN -
Fujian Medical University Union Hospital
collaborator OTHER -
The First Affiliated Hospital of Xiamen University
lead OTHER
Principal Investigators
-
Shi Guixiu, PhD · The First Affiliated Hospital of Xiamen University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-02-15
- Primary Completion
- 2025-12-20
- Completion
- 2028-12-20
Countries
- China
Study Locations
More Related Trials
-
Exploration of TNF-alpha Blockade With Golimumab in the Induction of Clinical Remission in Patients With Early Peripheral Spondyloarthritis (SpA) According to ASAS-criteria
NCT01426815 ·Status: COMPLETED ·Phase: PHASE3
-
Individualizing Anti-Inflammatory Medications for Adults With Axial Spondyloarthritis: A Series of N-of 1 Trials
NCT04115098 ·Status: TERMINATED ·Phase: PHASE2
-
NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis
NCT02758782 ·Status: COMPLETED ·Phase: PHASE4
-
Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis
NCT03473665 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active AS
NCT05212051 ·Status: UNKNOWN ·Phase: PHASE2
-
Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)
NCT00844805 ·Status: COMPLETED ·Phase: PHASE3
-
Characterizing Spondyloarthritis With 68Ga-FAPI PET/CT
NCT05999643 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis
NCT04169373 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back Pain
NCT01040195 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis
NCT01114880 ·Status: COMPLETED ·Phase: PHASE3
-
Fecal Microbiota Transplantation in Axial Spondyloarthritis
NCT06451588 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Spacing of Anti-TNF Drugs in Ankylosing Spondylitis With Low Disease Activity
NCT01610947 ·Status: COMPLETED ·Phase: NA
-
A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis
NCT06860750 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs
NCT01209702 ·Status: TERMINATED ·Phase: PHASE3
-
IL17 Rate and Spondyloarthritis
NCT05592574 ·Status: RECRUITING
-
A Clinical Study to Evaluate the Efficacy of Biologics in SpA
NCT04399382 ·Status: UNKNOWN
-
A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis
NCT05467995 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation
NCT03270501 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis
NCT06378697 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis
NCT05303285 ·Status: RECRUITING ·Phase: PHASE4
-
Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial
NCT01718951 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)
NCT06222671 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib in a Real-world Setting
NCT05094128 ·Status: RECRUITING
-
Methotrexate in the Treatment of Axial Spondyloarthritis
NCT00298012 ·Status: WITHDRAWN ·Phase: PHASE4
-
Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis
NCT01248793 ·Status: COMPLETED ·Phase: PHASE3